STOCKHOLM--(BUSINESS WIRE)--Regulatory News:
Moberg Pharma AB (OMX: MOB) today announced that a grant of EUR 0.9 million in public funding has been approved by Eurostars for a project proposal related to late-stage development of Moberg Pharma’s BUPI project.
Help employers find you! Check out all the jobs and post your resume.
